Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 109
Selected: 0
NCT IDTitle
NCT05222087PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study
NCT00234169A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone
NCT06279260National Robotics-Assisted Radical Prostatectomy Database
NCT03034577Deep Neuromuscular Block for Laparoscopic Surgery
NCT00335348Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse
NCT05560659Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
NCT07051525Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever
NCT00753727Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma
NCT05263700FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary
NCT05592938Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
NCT04769817ProsTIC Registry of Men Treated With PSMA Theranostics
NCT04343885In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy
NCT01676428A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases
NCT00193934Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer
NCT01742793An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
NCT06882499Stereotactic Ablative Body Radiotherapy (SABR) with Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II
NCT05063838Perioperative Pharmacogenomic Testing
NCT03464942Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer
NCT05983159A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
NCT05570227Metabolic Phenotypes in Melanoma
NCT04074460Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study
NCT00482261A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
NCT07213076Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.
NCT05154162PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI
NCT05864742Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma
NCT00110162Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
NCT05169177Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
NCT05024318NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
NCT06510699Pharmacogenomics for Better Treatment of Fungal Infections in Cancer
NCT05340374Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer
NCT02662062Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
NCT01658241Panobinostat Biological Correlates Study
NCT03331731A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma
NCT06812715Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib
NCT03299660Avelumab With Chemoradiation in Locally Advanced Rectal Cancer
NCT03874884177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer
NCT01716364Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT05053854PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours
NCT00206609The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer
NCT03287427MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial
NCT05095519Hepatocellular Carcinoma Imaging Using PSMA PET/CT
NCT04914741A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
NCT00418210Accelerated Partial Breast Irradiation for Early Breast Cancer
NCT01486459A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer
NCT03658447PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)
NCT06127654Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy
NCT02855203Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours
NCT03980171Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma
NCT03302728Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma
NCT05182931A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)